QD Quadramed Corp.

QuadraMed� Corporation (Amex:QD) today announced general availability of the QuadraMed M5 release. This release includes a comprehensive series of enhancements across the company�s Care-Based Revenue Cycle solutions for Access and Identity Management, Care Management, Health Information and Revenue Cycle Management. Developed in cooperation with QuadraMed clients, the release provides significant increases in overall functionality and capability to help clients improve their quality of care and leverage those improvements into positive financial performance. To improve quality and patient safety, QuadraMed M5 provides enhancements to nine Care Management products including QuadraMed Patient and Medication Charting, Order Management, Pharmaceutical Checking and the Clinical Workstation � Physician module, which incorporates Clinician Access and Documentation, Prescription Writing and CPOE (Computerized Physician Order Entry). These enhancements include substantial data retrieval and display improvements for ease of use, built-in Intelligent Care Sets� for reminders and patient care considerations, and alerts and warnings to further improve clinical decision support. The Emergency Department is the source for approximately fifty percent of the admissions for many hospitals. To improve efficiency and safety, the QuadraMed M5 release adds enhanced capability to track ED patients in the Access Management products. And to increase productivity in Health Information Management (HIM) departments, the release provides for improved workflow by centralizing access to the information used to efficiently code an encounter using the Medical Records Abstract/DRG product. Within QuadraMed�s Revenue Cycle Management solution, a major upgrade was made to the manner in which clinicians are identified and associated with a patient�s visit. The Revenue Cycle Management products now include support for the National Provider Identifier and identifying clinicians in roles other than physician. The highly rated QuadraMed EDI applications now provide greater support to the evolving use of 835 for posting payments and adjustments, and process enhancements were made for use in the creation of 837 electronic claims. QuadraMed�s Central Business Office product now includes exception-driven aggregator worklist functionality that can span multiple hospitals. The foundational components of the QuadraMed Care-Based Revenue Cycle include solutions for Access and Identity Management, Care, Health Information and Revenue Cycle Management. These end-to-end solutions are designed to optimize the patient experience and help clients to leverage quality care into financial health, enabling them to receive the proper reimbursement in the shortest time, at the lowest administrative cost. For information about all QuadraMed Care-Based Revenue Cycle solutions and related services, visit www.quadramed.com or call 800.393.0278. About QuadraMed Corporation QuadraMed Corporation advances the success of healthcare organizations through IT solutions that leverage quality care into positive financial outcomes. Using QuadraMed�s Care-Based Revenue Cycle solutions, which are designed to optimize the patient experience and leverage quality of care into payment, our clients seek to receive the proper reimbursement, in the shortest time, at the lowest administrative cost. QuadraMed delivers real-world solutions that help healthcare professionals deliver outstanding patient care with significant efficiency. Behind our products and services is a staff of 600 professionals whose experience and dedication to service have earned QuadraMed the trust and loyalty of customers at approximately 2,000 healthcare provider facilities. Cautionary Statement on Risks Associated with QuadraMed�s Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 by QuadraMed that are subject to risks and uncertainties. The words "believe," "expect," "anticipate," "intend," "plan," "estimate," "may," "should," "could," and similar expressions are intended to identify such statements. Forward-looking statements are not guarantees of future performance and are to be interpreted only as of the date on which they are made. QuadraMed undertakes no obligation to update or revise any forward-looking statement except as required by law. QuadraMed advises investors that it discusses risk factors and uncertainties that could cause QuadraMed�s actual results to differ from forward-looking statements in its periodic reports filed with the Securities and Exchange Commission ("SEC"). QuadraMed�s SEC filings can be accessed through the Investor Relations section of our website, www.quadramed.com, or through the SEC�s EDGAR Database at www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833). QuadraMed and Intelligent Care Sets are registered trademarks of QuadraMed Corporation. Care-Based Revenue Cycle is a trademark of QuadraMed Corporation. All other trademarks are the property of their respective holders.